Cardiogen at J.P. Morgan 2026

Munich, January 05, 2026 – Cardiogen GmbH, a preclinical clinical life science company focusing on cardiovascular regeneration and cellular reprogramming, is attending the annual J.P. Morgan Healthcare Conference in San Francisco.

The annual J.P. Morgan Healthcare Conference is the largest and most informative healthcare investment symposium in the industry, bringing together industry leaders, emerging fast-growth companies, innovative technology creators, and members of the investment community.

Cardiogen is presenting its technology and development program for cardiovascular diseases.

The event is taking place on January 12-15, 2026 in San Francisco, CA.

About Cardiogen

Cardiogen’s non-invasive regenerative approach can potentially play a significant role in improving the survival rate and quality of life for patients who experience a heart attack, as well as in various other cardiovascular diseases. 

For more information, visit: https://www.cardiogentx.com/ or contact info@cardiogentx.com